UNSPSC 51283935: Sulfadicramide

This classification denotes a sulfonamide antiinfective with the molecular formula C11H14N2O3S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 7WZ5EG263C, chemically known as n'-(3,3-dimethylacroyl)sulfanilamide but generally known as sulfadicramide, which bears US NIH Compound Identifier 8281. The term SULFADICRAMIDE is an International Non-Proprietary Name or INN. European Medicines Agency schedules sulfadicramide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB10697MIG.

Most nations schedule sulfadicramide under HS 29350090 and SITC 51580. As of Q4 2014, SULFADICRAMIDE remains the US FDA Preferred Term for this commodity. SMILES: CC(=CC(=O)NS(=O)(=O)C1=CC=C(C=C1)N)C.

UNSPSC 51283935 Sulfadicramide (Commodity) shows little relevant recent activity. The code nominally describes a specific pharmaceutical ingredient, but the four recent state and local opportunities posted under or near this code — spanning Florida, Texas, and Minnesota — procure naloxone and drug deactivation systems, therapeutic pharmacy programs, emergency medical supplies, and generic multi-source pharmaceuticals and OTC products. None of these solicitations target sulfadicramide or closely related sulfanilamide-class drugs. The opportunities indicate that state and local health agencies, fire departments, and cooperative purchasing organizations are actively buying pharmaceuticals, medical supplies, and pharmacy benefit management services, but the code itself does not appear to drive procurement activity in the way UNSPSC codes typically do.

Because the source does not support any opportunities actually soliciting sulfadicramide or products under this code's scope, and the four records present a mismatch between the code's nominal scope and what is being bought, the code warrants a skip unless your firm has established relationships with state health agencies, county emergency services, or cooperative purchasing alliances already engaged in broader pharmaceutical procurement. Activity under adjacent codes covering pharmaceutical products, emergency medical supplies, and pharmacy benefit services is robust and concentrated in state health and human services departments, but sulfadicramide itself does not surface as a procurement signal in the current state and local market.